Nasser Samadi
Overview
Explore the profile of Nasser Samadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
1679
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang D, Lu W, Samadi N
Chem Biol Drug Des
. 2022 Oct;
101(5):1042-1047.
PMID: 36217900
KIF4A has been demonstrated to play a crucial function in the pathogenesis of a broad number of tumors and have close association with PI3K/AKT pathway. The aim of this study...
2.
Mostafazadeh M, Kahroba H, Haiaty S, TazeKand A, Samadi N, Rahbarghazi R, et al.
Cell Biochem Funct
. 2022 Apr;
40(4):391-402.
PMID: 35474580
Chemotherapy resistance is a serious pitfall in the treatment of colon cancers (CCs). Previous studies have found that exosomes (Exo) play a pivotal role in tumor drug resistance via the...
3.
Kahroba H, Samadi N, Mostafazadeh M, Hejazi M, Sadeghi M, Hashemzadeh S, et al.
Bioimpacts
. 2022 Apr;
12(2):127-138.
PMID: 35411299
Exosomal microRNAs (miRNAs) are emerging diagnostic biomarkers for different types of cancers. We aim to detect gastric cancer (GC)-specific miRNAs in serum exosomes with diagnostic potential. A pair of 43...
4.
Molavi G, Samadi N, Hashemzadeh S, Halimi M, Zadeh Hosseingholi E
J Appl Biomed
. 2021 Dec;
18(2-3):46-53.
PMID: 34907725
Breast cancer is the most common malignancy among females worldwide. Recent studies have shown extra-ribosomal roles of the moonlight ribosomal proteins in the development of human cancers. Accurate quantification of...
5.
Baghban R, Farajnia S, Ghasemi Y, Mortazavi M, Ghasemali S, Zakariazadeh M, et al.
Iran J Med Sci
. 2021 Nov;
46(6):454-467.
PMID: 34840386
Background: Ocriplasmin has been developed for the induction of posterior vitreous detachment in patients with vitreomacular adhesion. At physiological pH, ocriplasmin is susceptible to autolytic and proteolytic degradation, limiting its...
6.
Payandeh Z, Pirpour Tazehkand A, Mansoori B, Khaze V, Asadi M, Baradaran B, et al.
Avicenna J Med Biotechnol
. 2021 Sep;
13(3):116-122.
PMID: 34484640
Background: Nuclear factor-erythroid 2-related factor 2 (Nrf2) plays a key role in promoting chemoresistance in various cancers. PD-L1 is one of the downstream targets of the Nrf2 signaling pathway. This...
7.
Jeddi F, Alipour S, Najafzadeh N, Dadashpour M, Pouremamali F, Sadeghi M, et al.
Galen Med J
. 2021 Sep;
8:e1329.
PMID: 34466494
Background: MicroRNAs (miRNAs) play critical roles in different pathological processes including cancer development and progression. To find novel molecular diagnostic and prognostic markers and promising therapeutic tools for gastric cancer...
8.
Hasanifard L, Samadi N, Rashtchizadeh N, Dastmalchi S, Karimi P
Drug Res (Stuttg)
. 2021 Sep;
68(1):e1.
PMID: 34465067
No abstract available.
9.
Ezzeddini R, Taghikhani M, Salek Farrokhi A, Somi M, Samadi N, Esfahani A, et al.
J Physiol Biochem
. 2021 Mar;
77(2):249-260.
PMID: 33730333
Lipid metabolism rewiring in gastric adenocarcinoma (GA) pathogenesis is still not clearly elucidated. This study aimed to describe the role of lipid catabolism in GA patient outcomes and possible therapeutic...
10.
Mostafazadeh M, Samadi N, Kahroba H, Baradaran B, Haiaty S, Nouri M
Cell Biosci
. 2021 Jan;
11(1):1.
PMID: 33407894
Drug resistance is a major impediment in cancer therapy which strongly reduces the efficiency of anti-cancer drugs. Exosomes are extracellular vesicles with cup or spherical shape with a size range...